Compare XOS & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XOS | BTMD |
|---|---|---|
| Founded | 2016 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.1M | 31.0M |
| IPO Year | 2020 | 2021 |
| Metric | XOS | BTMD |
|---|---|---|
| Price | $1.56 | $0.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $4.00 | $2.22 |
| AVG Volume (30 Days) | ★ 102.4K | 82.5K |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 59.49 | ★ 722.22 |
| EPS | N/A | ★ N/A |
| Revenue | $45,992,000.00 | ★ $192,219,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $90.13 | $2.95 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.58 | $0.83 |
| 52 Week High | $8.27 | $2.90 |
| Indicator | XOS | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 23.98 | 32.65 |
| Support Level | N/A | N/A |
| Resistance Level | $1.89 | $1.24 |
| Average True Range (ATR) | 0.24 | 0.08 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 2.51 | 5.86 |
Xos Inc is a fleet electrification solutions provider committed to the decarbonization of commercial transportation. Xos designs and manufactures Class 5 through 8 battery-electric commercial vehicles that travel on last-mile, back-to-base routes of up to 200 miles per day. Xos also offers charging infrastructure products and services through Xos Energy Solutions to support electric vehicle fleets. Its products include Stepvan, MDXT, HDXT, Xosphere, and Xos Energy Solutions.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.